RHOEN-KLINIKUM AG

RHK

Equity

ISIN DE0007042301 / Valor 341644

Xetra (2024-11-21)

EUR 12.50+0.81%

RHOEN-KLINIKUM AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

RHOEN-KLINIKUM AG is a German healthcare company that operates hospitals and medical facilities, providing a range of medical services to patients.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

In the fourth quarter of 2023, RHOEN-KLINIKUM AG reported a significant increase in revenue, reaching 1.46 billion euros. This growth was achieved despite the cessation of legislative reimbursements related to COVID-19.

Net Profit

RHOEN-KLINIKUM AG's net profit for Q4 2023 improved to 40.2 million euros, marking a positive development compared to the previous year. This increase underscores the company's effective financial management and operational efficiency.

EBITDA Performance

The earnings before interest, taxes, depreciation, and amortization (EBITDA) for RHOEN-KLINIKUM AG in Q4 2023 amounted to 105.9 million euros. This figure reflects the company's robust operational performance during the quarter.

Patient Treatment Numbers

During the fourth quarter of 2023, RHOEN-KLINIKUM AG treated a total of 881,775 patients across its clinics and medical centers. This represents a 3.1% increase in patient numbers compared to the same period in the previous year.

2024 Financial Outlook

Looking ahead to the fiscal year 2024, RHOEN-KLINIKUM AG projects revenue to be around 1.6 billion euros, with a possible variance of 5% either way. The company also anticipates an EBITDA in the range of 110 million to 120 million euros, reflecting continued confidence in its financial performance.

Summarized from source with an LLMView Source

Key figures

9.65%1Y

-20.4%3Y

-33.5%5Y

Performance

34.6%1Y

31.6%3Y

28.8%5Y

Volatility